Rossi Renata Calciolari, Anonni Raquel, Ferreira Diogenes Seraphim, da Silva Luiz Fernando Ferraz, Mauad Thais
1Department of Pathology, Universidade de São Paulo-School of Medicine, Avenida Dr. Arnaldo, 455., CEP 01246-903 São Paulo, SP Brazil.
2Department of Pathology, Universidade do Oeste Paulista, Presidente Prudente, São Paulo Brazil.
Allergy Asthma Clin Immunol. 2019 Aug 28;15:50. doi: 10.1186/s13223-019-0363-0. eCollection 2019.
There is interest in better understanding vessel pathology in asthma, given the findings of loss of peripheral vasculature associated with disease severity by imaging and altered markers of endothelial activation. To date, vascular changes in asthma have been described mainly at the submucosal capillary level of the bronchial microcirculation, with sparse information available on the pathology of bronchial and pulmonary arteries. The aim of this study was to describe structural and endothelial activation markers in bronchial arteries (BAs) and pulmonary arteries (PAs) of asthma patients who died during a fatal asthma attack.
Autopsy lung tissue was obtained from 21 smoking and non-smoking patients who died of an asthma attack and nine non-smoking control patients. Verhoeff-Masson trichrome staining was used to analyse the structure of arteries. Using immuno-histochemistry and image analyses, we quantified extracellular matrix (ECM) components (collagen I, collagen III, versican, tenascin, fibronectin, elastic fibres), adhesion molecules [vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1)] and markers of vascular tone/dysfunction [endothelin-1 (ET-1) and angiotensin II type 2 receptor (AT2)] in PAs and BAs.
There were no significant differences in ECM components, ICAM-1, ET-1 or AT2 between asthma patients and controls. Smoking asthma patients presented with decreased content of collagen III in both BA (p = 0.046) and PA (p = 0.010) walls compared to non-smoking asthma patients. Asthma patients had increased VCAM-1 content in the BA wall (p = 0.026) but not in the PA wall.
Our data suggest that the mechanisms linking asthma and arterial functional abnormalities might involve systemic rather than local mediators. Loss of collagen III in the PA was observed in smoking asthma patients, and this was compatible with the degradative environment induced by cigarette smoking. Our data also reinforce the idea that the mechanisms of leukocyte efflux via adhesion molecules differ between bronchial and pulmonary circulation, which might be relevant to understanding and treating the distal lung in asthma.
鉴于影像学显示外周血管减少与疾病严重程度相关,以及内皮细胞活化标志物改变,人们对更好地了解哮喘中的血管病理情况很感兴趣。迄今为止,哮喘中的血管变化主要在支气管微循环的黏膜下毛细血管水平进行描述,关于支气管和肺动脉病理的信息较少。本研究的目的是描述在致命哮喘发作期间死亡的哮喘患者的支气管动脉(BA)和肺动脉(PA)中的结构和内皮细胞活化标志物。
从21例死于哮喘发作的吸烟和非吸烟患者以及9例非吸烟对照患者获取尸检肺组织。采用Verhoeff - Masson三色染色法分析动脉结构。通过免疫组织化学和图像分析,我们对PA和BA中的细胞外基质(ECM)成分(I型胶原、III型胶原、多功能蛋白聚糖、腱生蛋白、纤连蛋白、弹性纤维)、黏附分子[血管细胞黏附分子1(VCAM - 1)和细胞间黏附分子1(ICAM - 1)]以及血管张力/功能障碍标志物[内皮素 - 1(ET - 1)和血管紧张素II 2型受体(AT2)]进行了定量分析。
哮喘患者与对照组在ECM成分、ICAM - 1、ET - 1或AT2方面无显著差异。与非吸烟哮喘患者相比,吸烟哮喘患者的BA(p = 0.046)和PA(p = 0.010)壁中III型胶原含量降低。哮喘患者的BA壁中VCAM - 1含量增加(p = 0.026),但PA壁中未增加。
我们的数据表明,将哮喘与动脉功能异常联系起来的机制可能涉及全身而非局部介质。在吸烟哮喘患者中观察到PA中III型胶原减少,这与吸烟诱导的降解环境相符。我们的数据还强化了这样一种观点,即通过黏附分子的白细胞外渗机制在支气管循环和肺循环之间存在差异,这可能与理解和治疗哮喘中的远端肺有关。